Takasago, Japan

Fumihiko Kanoo



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumihiko Kanoo: Innovator in Antibacterial Agents

Introduction

Fumihiko Kanoo is a notable inventor based in Takasago, Japan. He has made significant contributions to the field of antibacterial agents, particularly through his innovative work on rifamycin derivatives. His research focuses on developing compounds that exhibit strong antibacterial activity against various bacteria, including those responsible for serious infections.

Latest Patents

Kanoo holds a patent for a substituted benzoxazinorifamycin derivative and antibacterial agent. This rifamycin derivative is characterized by a specific formula wherein R¹ can be a hydrogen atom, methyl group, or ethyl group, and R² is an alkyl group with 1 to 4 carbon atoms. The compound demonstrates potent antibacterial activity against Gram-positive bacteria, acid-fast bacteria, and tubercle bacilli. He has 1 patent to his name, showcasing his innovative approach to combating bacterial infections.

Career Highlights

Fumihiko Kanoo is associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, a company known for its advancements in chemical and pharmaceutical research. His work at this institution has allowed him to focus on developing effective antibacterial agents that can address critical health challenges.

Collaborations

Kanoo has collaborated with esteemed colleagues such as Takehiko Yamane and Hideo Kondo. These partnerships have fostered a collaborative environment that enhances the research and development of new antibacterial compounds.

Conclusion

Fumihiko Kanoo's contributions to the field of antibacterial agents highlight his innovative spirit and dedication to improving public health. His work continues to influence the development of effective treatments against bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…